Article Details
Retrieved on: 2021-04-10 19:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
For the first time, researchers led by SU2C "Dream Team" show how CD40 agonist drives an immune response to hard-to-penetrate tumors. University ...
Article found on: www.eurekalert.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here